Corrigendum to "Development of a stable inhalable dry powder formulation with osteoglycin fragment for alveolar

Luke van der Koog1, Evalyne M Jansen2, Robin A B Elferink1

  • 1Department of Molecular Pharmacology, Groningen Research Institute of Pharmacy, Faculty of Science and Engineering, University of Groningen, Groningen, The Netherlands; GRIAC, Groningen Research Institute for Asthma and COPD, University Medical Center Groningen, Groningen, The Netherlands.

Abstract

No abstract available in PubMed .

Related Concept Videos